Niagen Bioscience says Niagen was the first nicotinamide riboside ingredient on the market and has now been studied in more than 45 peer-reviewed human clinical

Niagen Bioscience says Niagen was the first nicotinamide riboside ingredient on the market and has now been studied in more than 45 peer-reviewed human clinical trials. The company is using that research base to support broader development and brand expansion.